AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
BEVACIZUMAB in Côte d'Ivoire
5 products registered with AIRP — 1 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AVASTIN 100MG/4ML SOLUTION A DILUER POUR PERFUSION FLACON DE 4ML | E-2007-039 | F. HOFFMANN-LA ROCHE LTD | active | 3 Dec 2027 |
| BEVAAS 100MG/4ML SOLUTION A DILUER POUR PERFUSION BOITE DE 4ML | E-2019-1006 | HETERO LABS LIMITED | expired | 5 Feb 2024 |
| BEVAAS 400MG/16ML SOLUTION A DILUER POUR PERFUSION BOITE DE 16ML | E-2019-1007 | HETERO LABS LIMITED | expired | 5 Feb 2024 |
| YPEVA 400MG/16ML SOLUTION A DILUER POUR PERFUSION FLACON DE 16ML | MD/201524-0220 | SOTHEMA | expired | 24 Jan 2023 |
| YPEVA 100MG/4ML SOLUTION A DILUER POUR PERFUSION FLACON DE 4ML | MD/201524-0219 | SOTHEMA | expired | 24 Jan 2023 |
BEVACIZUMAB — AIRP Registration Details
AIRP (Côte d'Ivoire) has 5 registered products containing BEVACIZUMAB, of which 1 is currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track BEVACIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.